Aclaris Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 11/10/2025 | 14.25 M | $27.08 M | 0.00% | 11.63% |
| VIVO CAPITAL, LLC | 11/14/2025 | 8.89 M | $16.89 M | 0.00% | 7.25% |
| VANGUARD GROUP INC | 11/07/2025 | 6.52 M | $12.38 M | -2.20% | 5.32% |
| BLACKROCK, INC. | 11/12/2025 | 5.69 M | $10.81 M | 3.20% | 4.64% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 5.28 M | $10.03 M | -45.18% | 4.31% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 4.61 M | $8.76 M | -3.35% | 3.76% |
| MORGAN STANLEY | 11/14/2025 | 4.08 M | $7.75 M | 15.17% | 3.33% |
| DECHENG CAPITAL LLC | 11/14/2025 | 4.04 M | $7.68 M | 0.00% | 3.30% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.39 M | $4.54 M | -3.05% | 1.95% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.37 M | $4.51 M | -15.25% | 1.94% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 2.33 M | $4.42 M | -4.39% | 1.90% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.72 M | $3.26 M | -25.05% | 1.40% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.62 M | $3.08 M | 10.58% | 1.32% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 1.57 M | $2.98 M | 12.72% | 1.28% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.55 M | $2.95 M | -59.49% | 1.27% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 1.50 M | $2.85 M | -18.92% | 1.22% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.43 M | $2.72 M | 25.26% | 1.17% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 1.28 M | $2.43 M | 100.00% | 1.04% |
| BOLLARD GROUP LLC | 11/14/2025 | 1.23 M | $2.33 M | -9.38% | 1.00% |
| STATE STREET CORP | 11/14/2025 | 1.11 M | $2.11 M | 10.55% | 0.91% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 1.07 M | $2.03 M | 33.94% | 0.87% |
| ALDEBARAN CAPITAL, LLC | 11/10/2025 | 987.70 K | $1.88 M | -0.60% | 0.81% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 956.05 K | $1.82 M | 510.61% | 0.78% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 923.31 K | $1.75 M | -8.27% | 0.75% |
| JPMORGAN CHASE & CO | 11/26/2025 | 758.58 K | $1.44 M | 21.61% | 0.62% |
| THREE BRIDGE WEALTH ADVISORS, LLC | 10/21/2025 | 714.82 K | $1.36 M | 100.00% | 0.58% |
| NORTHERN TRUST CORP | 11/14/2025 | 700.82 K | $1.33 M | -8.54% | 0.57% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 544.76 K | $1.04 M | 6.95% | 0.44% |
| AISLING CAPITAL MANAGEMENT LP | 11/12/2025 | 434.46 K | $825.47 K | 0.00% | 0.35% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 393.32 K | $747.31 K | -11.28% | 0.32% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 373.68 K | $710.00 K | 100.00% | 0.30% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 368.11 K | $699.40 K | -50.90% | 0.30% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 350.10 K | $665.19 K | -54.19% | 0.29% |
| HIGHTOWER ADVISORS, LLC | 11/07/2025 | 309.32 K | $587.70 K | -3.88% | 0.25% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 283.48 K | $538.60 K | 2.24% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 241.96 K | $459.72 K | -7.40% | 0.20% |
| NUVEEN, LLC | 11/12/2025 | 237.83 K | $451.88 K | 0.00% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 220.08 K | $418.16 K | 2.24% | 0.18% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 192.90 K | $366.51 K | -60.74% | 0.16% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 164.24 K | $312.18 K | -20.76% | 0.13% |
| INVESCO LTD. | 11/13/2025 | 162.46 K | $308.68 K | 20.05% | 0.13% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 154.55 K | $293.65 K | -16.27% | 0.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 140.17 K | $267.00 K | -15.75% | 0.11% |
| BARCLAYS PLC | 11/12/2025 | 123.43 K | $234.51 K | -21.05% | 0.10% |
| UBS GROUP AG | 11/13/2025 | 105.14 K | $199.76 K | -31.36% | 0.09% |
| RHUMBLINE ADVISERS | 11/06/2025 | 91.24 K | $173.35 K | 7.38% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 75.19 K | $142.86 K | 3.58% | 0.06% |
| JANE STREET GROUP, LLC | 11/14/2025 | 73.11 K | $138.92 K | 100.00% | 0.06% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 68.04 K | $129.27 K | 8.27% | 0.06% |
| ALGERT GLOBAL LLC | 11/14/2025 | 65.63 K | $125.00 K | 64.69% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aclaris Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 140 institutional investors and hedge funds held shares of Aclaris Therapeutics, Inc.. The most heavily invested institutionals were:
BML Capital Management, LLC: 14.25 M
Vivo Capital, LLC: 8.89 M
VANGUARD GROUP INC: 6.52 M
BlackRock, Inc.: 5.69 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.28 M
Rock Springs Capital Management LP: 4.61 M
69.89% of Aclaris Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 92.80 M shares in the last 24 months. This purchase volume represents approximately $172.62 M in transactions.